Würth Finance International B.V.

  • WKN: A0NUTV
  • ISIN: DE000A0NUTV5
  • Land: Niederlande

Nachricht vom 28.08.2014 | 09:03

Würth Finance International B.V.: Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG [the German Securities Act] with the objective of Europe-wide distribution


Würth Finance International B.V.  / Preliminary announcement on the
disclosure of financial statements

28.08.2014 09:03

Announcement according to articles 37v, 37w, 37x ff. WpHG, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Würth Finance International B.V. hereby announces that the following financial reports shall be disclosed : Report: Financial report (half-year/Q2) Date of disclosure / German: August 29, 2014 Date of disclosure / English: August 29, 2014 German: http://www.wuerthfinance.net/index.php?id=42 English: http://www.wuerthfinance.net/index.php?id=42&L=1 Report: Financial report of the group (half-year/Q2) Date of disclosure / German: August 29, 2014 Date of disclosure / English: August 29, 2014 German: http://www.wuerthfinance.net/index.php?id=42 English: http://www.wuerthfinance.net/index.php?id=42&L=1 28.08.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: Würth Finance International B.V. Het Sterrenbeeld 35, P.O. Box 344 5201 's-Hertogenbosch Netherlands Internet: www.wuerthfinance.net End of Announcement DGAP News-Service

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie

3U HOLDING AG

Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021